HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a
Authors
Keywords
MTT assay, Transfection, Small interfering RNAs, Gene expression, Cancer treatment, Gastric cancer, Luciferase, Polymerase chain reaction
Journal
PLoS One
Volume 10, Issue 8, Pages e0132746
Publisher
Public Library of Science (PLoS)
Online
2015-08-21
DOI
10.1371/journal.pone.0132746
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hypoxia Induced Multidrug Resistance of Laryngeal Cancer Cells via Hypoxia-inducible Factor-1α
- (2013) Da-Wei Li et al. Asian Pacific Journal of Cancer Prevention
- Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells
- (2013) S Carbajo-Pescador et al. BRITISH JOURNAL OF CANCER
- HIF1 regulates WSB-1 expression to promote hypoxia-induced chemoresistance in hepatocellular carcinoma cells
- (2013) Ying Tong et al. FEBS LETTERS
- An Updated Report of the Trends in Cancer Incidence and Mortality in Japan
- (2013) Kota Katanoda et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells
- (2012) Jung-Chien Cheng et al. CANCER LETTERS
- HIF1α regulated expression of XPA contributes to cisplatin resistance in lung cancer
- (2012) Yanbin Liu et al. CARCINOGENESIS
- The TNF-α/ROS/HIF-1-induced Upregulation of FoxMI Expression Promotes HCC Proliferation and Resistance to Apoptosis
- (2012) Limin Xia et al. CARCINOGENESIS
- A Questionnaire-Based Survey on Screening for Gastric and Colorectal Cancer by Physicians in East Asian Countries in 2010
- (2012) Yuji Naito et al. DIGESTION
- MET Activation Mediates Resistance to Lapatinib Inhibition of HER2-Amplified Gastric Cancer Cells
- (2012) C.-T. Chen et al. MOLECULAR CANCER THERAPEUTICS
- SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors
- (2012) Marco Montagner et al. NATURE
- Hypoxia-Induced Modulation of Apoptosis and BCL-2 Family Proteins in Different Cancer Cell Types
- (2012) Audrey Sermeus et al. PLoS One
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells
- (2011) Xiaohong Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells
- (2011) Ke Xu et al. MOLECULAR CARCINOGENESIS
- Potential Applications of MicroRNAs in Cancer Diagnosis, Prognosis, and Treatment
- (2011) Sukhinder Sandhu et al. SEMINARS IN ONCOLOGY
- Genome-Wide Association Studies and Aggressive Surgery Toward Individualized Prevention, and Improved Local Control and Overall Survival for Gastric Cancer
- (2009) Dimitrios H. Roukos ANNALS OF SURGICAL ONCOLOGY
- Preoperative treatment and surgery in gastric cancer: friends or foes?
- (2009) Domenico D'Ugo et al. LANCET ONCOLOGY
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
- A microRNA component of the hypoxic response
- (2008) R Kulshreshtha et al. CELL DEATH AND DIFFERENTIATION
- Kruppel-like Factor 4 is Required for the Expression of Vascular Smooth Muscle Cell Differentiation Marker Genes Induced by All-Trans Retinoic Acid
- (2008) C. Wang et al. JOURNAL OF BIOCHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now